These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2882541)

  • 1. Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.
    Vaccheri A; Dall'Olio R; Gandolfi O; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1987; 91(3):394-6. PubMed ID: 2882541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.
    Dall'Olio R; Roncada P; Vaccheri A; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1989; 98(3):342-6. PubMed ID: 2568655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.
    Dall'Olio R; Gandolfi O
    Psychopharmacology (Berl); 1993; 110(1-2):165-8. PubMed ID: 7870878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarity of clozapine and SCH 23390 in reserpinized rats suggests a common mechanism of action.
    Chipkin RE; Latranyi MB
    Eur J Pharmacol; 1987 Apr; 136(3):371-5. PubMed ID: 2886345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390.
    Gessa GL; Porceddu ML; Collu M; Mereu G; Serra M; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Feb; 109(2):269-74. PubMed ID: 2859998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
    Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
    Arnt J; Hyttel J
    Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
    Parashos SA; Barone P; Marin CA; Paraschos AJ; Kapitzoglou-Logothetis V; Chase TN
    Psychopharmacology (Berl); 1989; 98(2):189-92. PubMed ID: 2569216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.
    Kropf W; Kuschinsky K; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6 Pt 2):718-25. PubMed ID: 2699354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models.
    Gerhardt S; Gerber R; Liebman JM
    Life Sci; 1985 Dec; 37(25):2355-63. PubMed ID: 3908866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
    Ljungberg T
    J Pharm Pharmacol; 1986 Jul; 38(7):520-5. PubMed ID: 2875153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NMDA positive modulator D-cycloserine inhibits dopamine-mediated behaviors in the rat.
    Dall'Olio R; Rimondini R; Gandolfi O
    Neuropharmacology; 1994 Jan; 33(1):55-9. PubMed ID: 7910387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.